Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06041802 |
|---|---|
| Brief Title: | A Study of MK-3475A (Pembrolizumab Formulated With MK-5180) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39) |
| First Submitted : | September 11, 2023 |
| First Submitted that Met QC Criteria : | September 11, 2023 |
| First Posted : | September 18, 2023 |
| Last Update Submitted that Met QC Criteria : | April 19, 2024 |
| Last Update Posted : | April 22, 2024 |